Treace Medical Concepts, Inc.

TMCI

US89455T1097

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
10.4 ^USD	+0.97%		-6.31%	-18.43%

Mar. 25	Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction	MT
Feb. 27	Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024

Treace Medical Concepts, Inc.(NasdaqGS:TMCI) added to S&P Healthcare Equipment Select Industry Index

September 19, 2022 at 12:00 am EDT

Latest news about Treace Medical Concepts, Inc.

Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction	Mar. 25	MT
Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Treace Medical Concepts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Reports Q4 Revenue $62.2M, vs. Street Est of $60.2M	Feb. 27	MT
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Year 2024	Feb. 27	CI
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
Treace Medical Concepts Says Post-Market Study of Lapiplasty Shows Patients Report 'Positive' Outcomes	Feb. 02	MT
Treace Medical Concepts, Inc. Announces Three-Year Interim Data from Its Align3d?? Post-Market Study Supporting the Use of the Lapiplasty Procedure for Treating Bunions	Feb. 02	CI
Transcript : Treace Medical Concepts, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 03:45 PM	Jan. 09
Treace Medical Concepts Expects Q4 Revenue of Up to $62 Million	Jan. 08	MT
Truist Securities Adjusts Price Target on Treace Medical Concepts to $16 From $12, Keeps Buy Rating	Dec. 22	MT
UBS Adjusts Price Target on Treace Medical Concepts to $17 From $24, Maintains Buy Rating	Nov. 13	MT
Morgan Stanley Adjusts Price Target on Treace Medical Concepts to $14 From $30, Maintains Overweight Rating	Nov. 13	MT
Truist Adjusts Price Target on Treace Medical Concepts to $12 From $17, Maintains Buy Rating	Nov. 10	MT
Sector Update: Health Care Stocks Advance Premarket Friday	Nov. 10	MT
Treace Medical Concepts Q3 Adjusted Loss Widens, Revenue Rises; Lowers Annual Revenue Outlook	Nov. 10	MT
Transcript : Treace Medical Concepts, Inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Posts Q3 Revenue $40.8M, vs. Street Est of $42.1M	Nov. 09	MT
Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Treace Medical Concepts, Inc. Revises Revenue Guidance for the Year 2023	Nov. 09	CI
UBS Initiates Treace Medical Concepts With Buy Rating, Price Target is $24	23-09-29	MT
Treace Medical Concepts, Inc. Highlights New Product Innovations and Updated Align3d Clinical Study Data At the American Orthopaedic Foot & Ankle Society Annual Meeting 2023	23-09-20	CI
Transcript : Treace Medical Concepts, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-12-2023 08:10 AM	23-09-12
Treace Medical Concepts, Inc. Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures	23-09-11	CI
North American Morning Briefing : Investors Look -2-	23-08-29	DJ

Chart Treace Medical Concepts, Inc.

Duration

Period

More charts

Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-07 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Treace Medical Concepts, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

10.3 USD

Average target price

15.86 USD

Spread / Average Target

+53.95%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
TREACE MEDICAL CONCEPTS, INC.	-18.43%	638M
SHOCKWAVE MEDICAL, INC.	+73.17%	12.34B
PENUMBRA, INC.	-18.74%	7.96B
MASIMO CORPORATION	+16.15%	7.16B
GETINGE AB	+4.81%	5.72B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+5.99%	5.03B
APT MEDICAL INC.	+27.07%	4.35B
ASAHI INTECC CO., LTD.	-21.67%	3.99B
INARI MEDICAL, INC.	-40.82%	2.21B
SKAN GROUP AG	+1.49%	2.01B

Medical Equipment